Albert Einstein College of Medicine: Diabetes Mellitus, Type 1 trials

The registry lists 10 Diabetes Mellitus, Type 1 studies with Albert Einstein College of Medicine as lead sponsor. 1 are open to participants now and 6 have results posted.

Phase 1 2Phase 2 1Phase 4 4No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and DepressionRecruitingNCT05734313Not applicable
• Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)TerminatedNCT03608163Phase 4Results posted
• Randomized Trial Comparing Sitagliptin to Placebo in Closed LoopCompletedNCT02328040Phase 1Results posted
• Liraglutide Versus Insulin Mono-therapy in the Closed Loop SettingCompletedNCT01755416Phase 2Results posted
• Sitagliptin Dose Determination StudyCompletedNCT01530178Phase 4Results posted
• Use of Exenatide and Pramlintide to Decrease Post-prandial HyperglycemiaCompletedNCT01269047Phase 4Results posted
• New Onset Type 1 Diabetes: Role of ExenatideCompletedNCT01269034Phase 4Results posted
• T1DTechCHW: Enhancing the Community Health Worker Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority GroupsCompletedNCT05211869Not applicable
• Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 DiabetesActive, not recruitingNCT05000021Not applicable
• Closed Loop System With Pramlintide Versus ExenatideCompletedNCT01269008Phase 1